Chest Pain | Pain During Chest Tube Withdrawal: Evaluation Using Pan Monitor
Chest Pain research study
What is the primary objective of this study?
Pain evaluation remains a clinical problem. Pain Monitor allows pain evaluation using the measurement of skin conductance. Withdrawal of chest tube can be painful and the purpose of the study was to compare auto-evaluation of pain (visual analogic scale) and the index measured by the Pain Monitor.
Who is eligible to participate?
Inclusion Criteria: - patients undergoing removal of a chest tube after lung surgery, - patients able to indicate the pain score. Exclusion Criteria: - pregnancy, lactation , - insulin-dependent diabetes with dysautonomia, - central or peripheral neurological disease, agitation, - inability to understand the protocol, - inability to use the Pain Monitor: skin abnormalities at the site of measurement, pacemaker or implantable defibrillator, condition affecting the sympathetic nervous system, tremor of the extremities, - contra-indication to oral morphine , - respiratory failure, severe hepatic insufficiency, intracranial hypertension, epilepsy associations - recent administration of neostigmine or of atropine.
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Procedure:Chest drain withdrawal
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Epidural analgesiaPostoperative patients with epidural analgesia
Oral analgesicsPostoperative patients with oral analgesics
Start Date: June 2013
Completed Date: May 2014
Primary Outcome: Pain monitor evaluation of pain
Secondary Outcome: Pain intensity
Study sponsors, principal investigator, and references
Principal Investigator: Marc Fischler
Lead Sponsor: Hopital Foch